VIA
RARE icon

Vident Investment Advisory’s Ultragenyx Pharmaceutical RARE Stock Holding History

Vident Investment Advisory’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,893
Closed -$272K – 800
2023
Q2 		$272K Buy
+5,893
New +$272K 0.01% 934